AIMM Therapeutics B.V.
Patent Applications and Registrations
Patent applications and USPTO patent grants for AIMM Therapeutics B.V..The latest application filed is for "therapeutic anti-cd9 antibody".
Company Profile
13.39.28
- AIMM Therapeutics B.V. - Amsterdam Zuidoost NL
- AIMM THERAPEUTICS B.V. - Amsterdam Zuidoost NL
- AIMM THERAPEUTICS B.V - Amsterdam Zuidoost NL
- AIMM THERAPEUTICS B.V. - BA AMSTERDAM NL
Patent Activity
| Patent | Date |
|---|---|
| Therapeutic Anti-CD9 Antibody App 20220064323 - SPITS; Hergen ; et al. | 2022-03-03 |
| Therapeutic anti-CD9 antibody Grant 11,136,407 - Spits , et al. October 5, 2 | 2021-10-05 |
| Means and methods for influencing the stability of cells Grant 10,774,308 - Spits Sept | 2020-09-15 |
| Means And Methods For Counteracting Myeloproliferative Or Lymphoproliferative Disorders App 20200239593 - SPITS; Hergen ; et al. | 2020-07-30 |
| Means and methods for determining T cell recognition Grant 10,690,658 - Linnemann , et al. | 2020-06-23 |
| Ex Vivo Antibody Production App 20200149007 - VAN HELDEN; PAULA MARIA WILHELMINA ; et al. | 2020-05-14 |
| Means and methods for producing stable antibodies Grant 10,611,829 - Kwakkenbos , et al. | 2020-04-07 |
| Means and methods for counteracting myeloproliferative or lymphoproliferative disorders Grant 10,556,963 - Spits , et al. Feb | 2020-02-11 |
| Hepatitis C virus specific antibody Grant 10,435,463 - Beaumont , et al. O | 2019-10-08 |
| Means and methods for producing high affinity antibodies Grant 10,344,076 - Beaumont , et al. July 9, 2 | 2019-07-09 |
| Means and methods for influencing the stability of antibody producing cells Grant 10,273,454 - Spits , et al. | 2019-04-30 |
| Therapeutic Anti-CD9 Antibody App 20190023803 - SPITS; Hergen ; et al. | 2019-01-24 |
| Means And Methods For Influencing The Stability Of Cells App 20180371410 - SPITS; Hergen | 2018-12-27 |
| Gram-positive Bacteria Specific Binding Compounds App 20180292391 - BEAUMONT; Tim ; et al. | 2018-10-11 |
| Means and methods for influencing the stability of cells Grant 10,077,427 - Spits September 18, 2 | 2018-09-18 |
| Aml Antigens And Uses Thereof App 20180170998 - SPITS; Hergen ; et al. | 2018-06-21 |
| Means and methods for producing high affinity antibodies Grant 9,969,795 - Beaumont , et al. May 15, 2 | 2018-05-15 |
| Gram-positive bacteria specific binding compounds Grant 9,927,428 - Beaumont , et al. March 27, 2 | 2018-03-27 |
| Rsv G Protein Specific Antibodies App 20170342134 - Beaumont; Tim ; et al. | 2017-11-30 |
| Means and methods for influencing the stability of antibody producing cells Grant 9,822,339 - Spits , et al. November 21, 2 | 2017-11-21 |
| Hepatitis C Virus Specific Antibody App 20170313764 - BEAUMONT; Tim ; et al. | 2017-11-02 |
| Influenza A Virus Specific Antibodies App 20170313766 - SPITS; Hergen ; et al. | 2017-11-02 |
| Means And Methods For Influencing The Stability Of Antibody Producing Cells App 20170306293 - SPITS; HERGEN ; et al. | 2017-10-26 |
| RSV G protein specific antibodies Grant 9,718,876 - Beaumont , et al. August 1, 2 | 2017-08-01 |
| Influenza A virus specific antibodies Grant 9,718,874 - Spits , et al. August 1, 2 | 2017-08-01 |
| Gram-positive bacteria specific binding compounds Grant 9,688,745 - Beaumont , et al. June 27, 2 | 2017-06-27 |
| Means And Methods For Determining T Cell Recognition App 20170160269 - Linnemann; Carsten ; et al. | 2017-06-08 |
| Gram-positive Bacteria Specific Binding Compounds App 20170067880 - BEAUMONT; Tim ; et al. | 2017-03-09 |
| Ex Vivo Antibody Production App 20170009205 - VAN HELDEN; Pauline Maria Wilhelmina ; et al. | 2017-01-12 |
| Means And Methods For Producing Stable Antibodies App 20170008952 - KWAKKENBOS; Mark Jeroen ; et al. | 2017-01-12 |
| Means And Methods For Counteracting Myeloproliferative Or Lymphoproliferative Disorders App 20160326261 - SPITS; Hergen ; et al. | 2016-11-10 |
| Gram-positive bacteria specific binding compounds Grant 9,458,228 - Beaumont , et al. October 4, 2 | 2016-10-04 |
| Gram-positive Bacteria Specific Binding Compounds App 20160222096 - Beaumont; Tim ; et al. | 2016-08-04 |
| Gram-positive bacteria specific binding compounds Grant 9,399,673 - Beaumont , et al. July 26, 2 | 2016-07-26 |
| Means And Methods For Producing High Affinity Antibodies App 20160194382 - BEAUMONT; Tim ; et al. | 2016-07-07 |
| Gram-positive Bacteria Specific Binding Compounds App 20160168232 - BEAUMONT; Tim ; et al. | 2016-06-16 |
| Means And Methods For Producing High Affinity Antibodies App 20160096881 - BEAUMONT; Tim ; et al. | 2016-04-07 |
| Means And Methods For Influencing The Stability Of Antibody Producing Cells App 20160060598 - Spits; Hergen ; et al. | 2016-03-03 |
| Means and methods for producing high affinity antibodies Grant 9,273,118 - Beaumont , et al. March 1, 2 | 2016-03-01 |
| Gram-positive bacteria specific binding compounds Grant 9,266,943 - Beaumont , et al. February 23, 2 | 2016-02-23 |
| Gram-positive Bacteria Specific Binding Compounds App 20150376266 - BEAUMONT; Tim ; et al. | 2015-12-31 |
| Means and methods for producing high affinity antibodies Grant 9,206,247 - Beaumont , et al. December 8, 2 | 2015-12-08 |
| Means and methods for influencing the stability of antibody producing cells Grant 9,127,251 - Spits , et al. September 8, 2 | 2015-09-08 |
| Gram-positive bacteria specific binding compounds Grant 9,090,677 - Beaumont , et al. July 28, 2 | 2015-07-28 |
| Means And Methods For Influencing The Stability Of Cells App 20150203816 - SPITS; Hergen | 2015-07-23 |
| Means and methods for influencing the stability of cells Grant 9,005,974 - Spits April 14, 2 | 2015-04-14 |
| Rsv G Protein Specific Antibodies App 20150004155 - Beaumont; Tim ; et al. | 2015-01-01 |
| Gram-positive bacteria specific binding compounds Grant 8,617,556 - Beaumont , et al. December 31, 2 | 2013-12-31 |
| Means And Methods For Producing High Affinity Antibodies App 20130331552 - Beaumont; Tim ; et al. | 2013-12-12 |
| Rsv Specific Binding Molecule App 20120070446 - BEAUMONT; TIM ; et al. | 2012-03-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 